TXA6101 is a bacterial protein FtsZ (filamentous temperature-sensitive protein Z) inhibitor that inhibits bacterial cell division; it exhibits potent antibacterial activity against MRSA isolates expressing G193D or G196S FtsZ mutants with MIC values of 1 μg/mL, retaining significant activity against TXA707-resistant FtsZ mutants; it has potential as a therapeutic agent against Gram-negative bacterial infections.